November 05, 2015.
Technology
Latest News
November 9th 2015
By Julian Upton
In Pharm Exec’s 2013 end-of-year supply chain roundup, we began with a three-word vision of the immediate future that left little room for ambiguity: “Serialization is coming.” With the impending laws regarding “track and trace” promising to alter the way pharmaceuticals are packaged and shipped, we outlined how global pharma was gearing up to deal with the effects of serialization, and how companies needed to review their own internal practices and those of their outsourcing partners, as the need for technology solutions for both sides of the outsourc
Advertisement
Advertisement
Pharmaceutical Executive
November 04, 2015.
Earlier this month, the Get Together Group (G2G) hosted its First Annual Leadership Conference in New Brunswick, NJ. Its goal - to provide mentoring and education to afford members a pathway to the “V-Suite” (Vice President Level).
November 02, 2015.
November 02, 2015.
November 02, 2015.
November 03, 2015.
The merger announcement from Walgreens Boots Alliance and Rite Aid throws up an interesting question, writes Stephen Littlejohn. Will Walgreens be purveyor focused on retail sales or provider engaged with a transforming U.S. healthcare system?
October 30, 2015.
Pharmaceutical Executive
October 28, 2015.
October 28, 2015.
October 27, 2015.
October 26, 2015.
October 26, 2015.
Pharmaceutical Executive
October 22, 2015.
Pharmaceutical Executive
October 22, 2015.
October 19, 2015.
October 19, 2015.
Pharmaceutical Executive
Medicine is entering a new era of “gene editing.” Instead of simply being able to “read” our genes, practitioners will be able to adapt and modify DNA sequencing in living cells to treat, cure, and even prevent disease. Defective genes responsible for life-threatening diseases can be rendered harmless by gene editing; it can also be used to develop new, precisely targeted biological drugs based on an individual’s distinct genetic markers. The full list of possibilities, in every area of the life sciences, is simply beyond imagination.
Advertisement
Advertisement
Trending on PharmExec
1
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
2
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
3
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
4
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
5